JOURNAL OF BUON, cilt.24, sa.3, ss.1081-1086, 2019 (SCI İndekslerine Giren Dergi)
Purpose: To analyze the reliability and the effectiveness of chemotherapy and prognostic factors for survival in patients with HER2 (human epidermal growth receptor 2) negative early-stage breast cancer treated with adjuvant sequential anthracycline-based chemotherapy and paclitaxel.